ArticleCellular oncology (Dordrecht, Netherlands)2023

Targeted CRISPR activation and knockout screenings identify novel doxorubicin transporters.

Yufeng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.